AADI BIOSCIENCE INC's ticker is and the CUSIP is 00032Q104. A total of 46 filers reported holding AADI BIOSCIENCE INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,170 | -30.3% | 9,126 | -1.5% | 0.00% | – |
| Q2 2023 | $63,373 | +36.3% | 9,265 | +44.2% | 0.00% | – |
| Q1 2023 | $46,510 | -27.9% | 6,424 | +27.8% | 0.00% | – |
| Q4 2022 | $64,470 | -68.1% | 5,025 | -69.4% | 0.00% | – |
| Q2 2022 | $202,000 | -79.0% | 16,434 | -71.0% | 0.00% | – |
| Q1 2022 | $961,000 | +65.4% | 56,684 | +135.3% | 0.00% | – |
| Q4 2021 | $581,000 | +8200.0% | 24,094 | +9939.2% | 0.00% | – |
| Q3 2021 | $7,000 | – | 240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 26,666 | $193,062 | 17.76% |
| Alerce Investment Management, L.P. | 1,630,830 | $11,807,209 | 15.60% |
| ACUTA CAPITAL PARTNERS, LLC | 1,849,402 | $13,389,670 | 9.86% |
| Decheng Capital Management III (Cayman), LLC | 526,329 | $3,810,622 | 1.54% |
| Knott David M Jr | 183,688 | $1,330 | 0.52% |
| Vivo Capital, LLC | 509,572 | $6,456,277 | 0.45% |
| Ghost Tree Capital, LLC | 150,000 | $1,086,000 | 0.32% |
| Avoro Capital Advisors LLC | 2,849,402 | $20,629,670 | 0.31% |
| Parkman Healthcare Partners LLC | 75,961 | $549,958 | 0.12% |
| RA Capital Management | 590,218 | $4,273,178 | 0.10% |